PRMT2 and breast cancer: In particular, alternatively spliced variants of PRMT2 were related to survival and the invasiveness of breast cancer cells [60,61], while high expression of RARG and HOXA9 has been observed in human hepatocellular carcinomas and acute leukemia [62,63].